Table 2 Baseline demographic and disease features characteristics based on CD4

CD4+ T cells

593.3 ± 188.34

342.08 ± 106.84

<0.01

Age (mean ± SD, years)

50.24 ± 9.05

50.07 ± 12.07

0.920

Male

67 (78.8%)

68 (80%)

0.850

BMI (mean ± SD, kg/m2)

21.95 ± 2.12

21.95 ± 1.88

1.000

HB (mean ± SD,g/dl)

131.19 ± 20.65

128.76 ± 19.01

0.426

CRE (mean ± SD,μmol/L)

64.65 ± 21.26

64.98 ± 11.55

0.901

Maximum tumor diameter (mean ± SD, mm)

0.41 ± 0.50

0.34 ± 0.48

0.345

Serum AFP > 400 ng/mL

66 (77.6%)

60 (70.6%)

0.293

Number of tumor ≥2

62 (72.9%)

52 (61.2%)

0.103

Plt (mean ± SD,109/L)

130.32 ± 50.68

130.09 ± 38.79

0.974

ALT (mean ± SD, u/L)

42.25 ± 19.95

47.78 ± 25.22

0.115

AST mean ± SD, u/L)

76.55 ± 49.96

73.68 ± 36.89

0.671

Alb (mean ± SD,g/L)

39.58 ± 6.57

38.84 ± 5.20

0.419

PT (mean ± SD, s)

13.84 ± 1.75

14.78 ± 2.97

0.013

TB (mean ± SD,μmol/L)

23.74 ± 12.37

21.52 ± 10.32

0.206

Child-Pugh score (mean ± SD)

6.09 ± 1

5.94 ± 0.94

0.305

Child-Pugh A

59 (69.4%)

68 (80%)

0.112

Child-Pugh B

26 (30.6%)

17 (20%)

0.112

Child-Pugh C

–

–

–

APRI

1.59 ± 1.14

1.52 ± 0.92

0.658

FIB-4

5.22 ± 3.83

5.11 ± 4.05

0.861